Skip to content

Testing the effectiveness and acceptability of a short, individualized diabetes self-management program that targets active coping skills, for adults aged 18 to 50 years with type 1 diabetes.

A pilot behavioural intervention targeting diabetes self-management and active coping skills for adults with type 1 diabetes: exploring pathways to psychological and glycaemic outcomes.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12620000905965
Enrollment
12
Registered
2020-09-14
Start date
2020-11-20
Completion date
2023-05-11
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will test a (one to one) diabetes self-management intervention that targets active coping with diabetes related goals, that are identified as most important to the individual throughout the intervention. We will test if this style of intervention is acceptable and effective and results in positive changes in diabetes self-management, glucose levels and well-being measures including diabetes distress. There will be the opportunity for some or all of the study visits to be completed remotely (e.g., via phone, or online platform). To be eligible for this study you will be aged from 18 to 50 years, diagnosed with type 1 diabetes for at least one year, your HbA1c within the preceding 6 months was at or above 8% OR based on your score on a diabetes distress survey. Information will be collected via surveys, medical records where possible, and some self-reported information.

Interventions

The intervention is a Conjoint Behavioural Consultation Model design, to target diabetes self-management knowledge and behaviours, with input from a consultant (clinical psychologist with extensive experience working with people with diabetes), consultee (experienced diabetes nurse educator) and the individual participant with type 1 diabetes. The intervention requires 6 individual (up to 1 hour) sessions over approximately 8 weeks, via a combination of face to face and remote/ virtual visits.

The intervention is a Conjoint Behavioural Consultation Model design, to target diabetes self-management knowledge and behaviours, with input from a consultant (clinical psychologist with extensive experience working with people with diabetes), consultee (experienced diabetes nurse educator) and the individual participant with type 1 diabetes. The intervention requires 6 individual (up to 1 hour) sessions over approximately 8 weeks, via a combination of face to face and remote/ virtual visits. After the intervention phase, there is one follow up visit at 3 months and again at 6 months. Data collection includes self-reported diabetes self-management actions, surveys and clinical measures such as glycated hemoglobin. Principles of diabetes self-management education and behavioural psychology will guide the intervention, that will target active coping and positive diabetes self-management behaviours with the aim of improving diabetes related health outcomes.

Sponsors

University of Western Australia
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Other
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of type 1 diabetes for at least 12 months 2. Aged 18 to 50 years. 3. Glycated haemoglobin within the previous 6 months > 8% And/ OR clinically significant diabetes distress score

Exclusion criteria

1. Pregnancy or breastfeeding 2. Non-English speaking 3. A level of disability that prevents independence in diabetes self-management. 4. A psychiatric disorder which in the opinion of the researchers would preclude participation in the intervention. 5. Inability to adhere to the protocol and study visits. 6. Use of Psychotropic medication will not automatically be an exclusion criteria, if the dosage has been stable for the past 3 months and will continue to be stable during the intervention period. Any changes in medication during the study period will be noted along with the other measurements at all stages.

Outcome results

None listed

Source: ANZCTR · Data processed: Jul 3, 2026